Mylan news
Mylan Inc. (Mylan), formerly Mylan Laboratories Inc., News
Mylan's President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
PITTSBURGH, Nov. 18 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that Didier Barret, president of Mylan Europe, Middle East and Africa (EMEA), has been elected president of the European Generic Medicines Association (EGA). Barret was elected to a two-year term earlier today at the EGA annual meeting being held in Brussels.
Merger Arbitrage, Beneficial Ownership Reporting and Proxy Contests: The SEC's Perry Order
Merger Arbitrage, Beneficial Ownership Reporting and Proxy Contests: The SEC's Perry Order
Linex Legal - 23 minutes ago
Source: Latham & Watkins LLP - Earlier this year, on July 21, 2009, the US Securities and Exchange Commission issued a cease-and-desist order charging investment adviser Perry Corp. (Perry) with ...
Another Win for Mylan
Another Win for Mylan
Zacks.com - 44 minutes ago
Recently, Mylan Inc.'s (MYL - Analyst Report) subsidiary, Matrix Laboratories received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA ...
Ratiopharm Attracts At Least 10 First Round Bids Including Mylan Inc.-Reuters
Ratiopharm Attracts At Least 10 First Round Bids Including Mylan Inc.-Reuters
Reuters Key Development - 4 hours ago
Mylan (MYL) Getse FDA Ok for Generic Prevacid
Mylan (MYL) Getse FDA Ok for Generic Prevacid
StreetInsider.com - 3 minutes ago
Mylan Inc. (Nasdaq: MYL) received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Lansoprazole Delayed-release (DR) Capsules, 15 mg and 30 mg. This product is ...
New Report Just Published Mylan, Inc. - Detailed Product Pipeline
New Report Just Published Mylan, Inc. - Detailed Product Pipeline
Live-PR.com - 49 minutes ago
(live-PR.com) - Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue. contain detailed information on pipelines by ...
Big Pharma And Biotech - Industry Outlook
Big Pharma And Biotech - Industry Outlook
istockAnalyst.com - 23 minutes ago
The pharmaceutical industry has witnessed major changes in 2009. Performance has been affected by factors like sluggish prescription trends, intensifying generic competition and limited phase III ...
